Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Szostak

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Gene|September 30, 1998
Cold-sensitive E-lysis systemsW Jechlinger, M P Szostak, W Lubitz
Cytometry|May 30, 2001
Green fluorescent protein (GFP)-dependent separation of bacterial ghosts from intact cells by FACSW Haidinger, M P Szostak, W Beisker, et al.
FEMS Microbiology Letters|May 5, 1999
Altered temperature induction sensitivity of the lambda pR/cI857 system for controlled gene E expression in Escherichia coliW Jechlinger, M P Szostak, A Witte, et al.
Applied and Environmental Microbiology|January 7, 2003
Online monitoring of Escherichia coli ghost productionW Haidinger, M P Szostak, W Jechlinger, et al.
Vaccine|October 1, 1994
Production of Vibrio cholerae ghosts (VCG) by expression of a cloned phage lysis gene: potential for vaccine developmentF O Eko, M P Szostak, G Wanner, et al.
Applied and Environmental Microbiology|October 9, 2003
Escherichia coli ghost production by expression of lysis gene E and Staphylococcal nucleaseW Haidinger, U B Mayr, M P Szostak, et al.
Vaccine|February 1, 1997
Endotoxicity does not limit the use of bacterial ghosts as candidate vaccinesH J Mader, M P Szostak, A Hensel, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 2, 1999
Bacterial ghosts as drug carrier and targeting vehiclesV Huter, M P Szostak, J Gampfer, et al.
Vaccine|August 19, 2003
Pasteurella multocida- and Pasteurella haemolytica-ghosts: new vaccine candidatesJ Marchart, G Dropmann, S Lechleitner, et al.
Journal of Biotechnology|September 16, 1999
Pigs aerogenously immunized with genetically inactivated (ghosts) or irradiated Actinobacillus pleuropneumoniae are protected against a homologous aerosol challenge despite differing in pulmonary cellular and antibody responsesA Katinger, W Lubitz, M P Szostak, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Gene|September 30, 1998
Cold-sensitive E-lysis systemsW Jechlinger, M P Szostak, W Lubitz
Cytometry|May 30, 2001
Green fluorescent protein (GFP)-dependent separation of bacterial ghosts from intact cells by FACSW Haidinger, M P Szostak, W Beisker, et al.
FEMS Microbiology Letters|May 5, 1999
Altered temperature induction sensitivity of the lambda pR/cI857 system for controlled gene E expression in Escherichia coliW Jechlinger, M P Szostak, A Witte, et al.
Applied and Environmental Microbiology|January 7, 2003
Online monitoring of Escherichia coli ghost productionW Haidinger, M P Szostak, W Jechlinger, et al.
Vaccine|October 1, 1994
Production of Vibrio cholerae ghosts (VCG) by expression of a cloned phage lysis gene: potential for vaccine developmentF O Eko, M P Szostak, G Wanner, et al.
Applied and Environmental Microbiology|October 9, 2003
Escherichia coli ghost production by expression of lysis gene E and Staphylococcal nucleaseW Haidinger, U B Mayr, M P Szostak, et al.
Vaccine|February 1, 1997
Endotoxicity does not limit the use of bacterial ghosts as candidate vaccinesH J Mader, M P Szostak, A Hensel, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 2, 1999
Bacterial ghosts as drug carrier and targeting vehiclesV Huter, M P Szostak, J Gampfer, et al.
Vaccine|August 19, 2003
Pasteurella multocida- and Pasteurella haemolytica-ghosts: new vaccine candidatesJ Marchart, G Dropmann, S Lechleitner, et al.
Journal of Biotechnology|September 16, 1999
Pigs aerogenously immunized with genetically inactivated (ghosts) or irradiated Actinobacillus pleuropneumoniae are protected against a homologous aerosol challenge despite differing in pulmonary cellular and antibody responsesA Katinger, W Lubitz, M P Szostak, et al.
Pageof 2